New research has found a way to diagnose Alzheimer’s disease (AD) earlier by analyzing biomarkers in blood. This could help reduce the effects of...
Vous n'êtes pas connecté
Dementia Australia has welcomed the recent approval of Lecanemab by the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA). This development marks a significant advance in the battle against Alzheimer’s disease, offering renewed optimism for those affected by this debilitating condition. Lecanemab, produced by the pharmaceutical company Eisai, has been making waves across the globe. […]
New research has found a way to diagnose Alzheimer’s disease (AD) earlier by analyzing biomarkers in blood. This could help reduce the effects of...
A team of researchers in Japan has discovered a potential new way to treat Alzheimer’s disease using dopamine, a chemical naturally produced in the...
A team of researchers in Japan has discovered a potential new way to treat Alzheimer’s disease using dopamine, a chemical naturally produced in the...
THURSDAY, Sept. 11, 2024 -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been...
New research from the University of Kentucky’s Sanders-Brown Center on Aging has revealed that the cognitive impairments seen in long COVID patients...
Cognitive decline and dementia can be caused by illnesses like Alzheimer’s disease and conditions like high blood pressure, which damage blood...
When seniors forget something, they may worry that they have Alzheimer’s disease or dementia. Only a small percentage of individuals develop...
WASHINGTON, USA – The Pan American Health Organization (PAHO) and Alzheimer’s Disease International (ADI) launched the #TimeToActOnDementia...
WASHINGTON, USA – The Pan American Health Organization (PAHO) and Alzheimer’s Disease International (ADI) launched the #TimeToActOnDementia...
Ivan Zhakata Herald Correspondent The Medicines Control Authority of Zimbabwe (MCAZ) has renewed its Memorandum of Understanding (MoU) with the...